Kaya Murtaza, Irk Ceyda Nur, Ulu Mehmed, Yildirim Harun, Toprak Mehmet, Eksert Sami
Department of Emergency Medicine, Faculty of Medicine, Kutahya Health Sciences University, Kutahya 43100, Turkey.
Department of Cardiology, Faculty of Medicine, Kutahya Health Sciences University, Kutahya 43100, Turkey.
Healthcare (Basel). 2025 Aug 27;13(17):2139. doi: 10.3390/healthcare13172139.
: Mechanical ventilatory support is often required in patients with acute respiratory distress syndrome (ARDS). However, early differences in ventilatory mechanics and severity scores between COVID-19 and non-COVID-19 ARDS patients remain unclear. This study aimed to compare respiratory parameters and clinical severity scores in COVID-19 and non-COVID-19 ARDS patients managed in the emergency department (ED) and evaluate their association with in-hospital mortality. In this retrospective cohort study, adult patients with ARDS (PaO/FiO < 300 mmHg) who received mechanical ventilation in the ED were included. Ventilator parameters and clinical severity scores (SOFA, APACHE II, PSI, and Charlson Comorbidity Index) were recorded at the 120th minute after intubation. Patients were categorized as COVID-19 or non-COVID-19 ARDS, and outcomes were compared between survivors and non-survivors. Logistic regression was used to identify independent predictors of in-hospital mortality. A total of 70 patients were enrolled (32 COVID-19, 38 non-COVID). Plateau pressure, driving pressure, and PEEP were significantly higher in COVID-19 patients, while compliance was without statistical significance. Overall, in-hospital mortality did not differ significantly between the COVID-19 (53.1%) and non-COVID-19 groups (71.1%, = 0.12). Mechanical power (21.6 vs. 16.8 J/min, = 0.01) and Charlson Comorbidity Index (6 vs. 5.5, = 0.02) were significantly higher in non-survivors across the full cohort. Among clinical scores, SOFA was significantly higher in the COVID-19 group ( = 0.02), and APACHE II was significantly higher in non-survivors within the COVID-19 subgroup ( = 0.02). In multivariate analysis, mechanical power and Charlson Comorbidity Index were associated with mortality. COVID-19 patients with ARDS exhibited higher early ventilatory pressures than non-COVID-19 patients, yet early respiratory mechanics were not independently associated with mortality. Mechanical power and Charlson Comorbidity Index were significantly associated with in-hospital mortality. These findings underscore the need to consider both ventilatory load and systemic health status in early outcome assessments of ARDS patients.
急性呼吸窘迫综合征(ARDS)患者常需机械通气支持。然而,新型冠状病毒肺炎(COVID-19)与非COVID-19的ARDS患者在通气力学和严重程度评分方面的早期差异仍不明确。本研究旨在比较在急诊科(ED)接受治疗的COVID-19和非COVID-19的ARDS患者的呼吸参数和临床严重程度评分,并评估它们与院内死亡率的相关性。在这项回顾性队列研究中,纳入了在ED接受机械通气的ARDS成年患者(动脉血氧分压/吸入氧浓度<300 mmHg)。在插管后第120分钟记录呼吸机参数和临床严重程度评分(序贯器官衰竭评估量表(SOFA)、急性生理与慢性健康状况评分系统II(APACHE II)、肺炎严重指数(PSI)和查尔森合并症指数)。患者被分为COVID-19或非COVID-19的ARDS,并比较幸存者和非幸存者的结局。采用逻辑回归分析确定院内死亡的独立预测因素。共纳入70例患者(32例COVID-19患者,38例非COVID患者)。COVID-19患者的平台压、驱动压和呼气末正压(PEEP)显著更高,而顺应性无统计学意义。总体而言,COVID-19组(53.1%)和非COVID-19组(71.1%,P = 0.12)的院内死亡率无显著差异。全队列中非幸存者的机械功率(21.6对16.8 J/min,P = 0.01)和查尔森合并症指数(6对5.5,P = 0.02)显著更高。在临床评分中,COVID-19组的SOFA显著更高(P =